Trials / Terminated
TerminatedNCT01107899
Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
Recovery of Platelet Function After a Loading Dose of Prasugrel or Clopidogrel in Aspirin-Treated Subjects Presenting With Symptoms of Acute Coronary Syndromes
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To investigate how platelets recover to normal function in subjects who have symptoms of a heart attack or unstable angina and who get a loading dose of prasugrel or clopidogrel for planned coronary angiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clopidogrel | taken orally, day one, single dose |
| DRUG | prasugrel | taken orally, day one, single dose |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-04-21
- Last updated
- 2012-03-09
- Results posted
- 2012-01-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01107899. Inclusion in this directory is not an endorsement.